share_log

Medpace Holdings (NASDAQ:MEDP) Shareholders Have Earned a 48% CAGR Over the Last Five Years

Medpace Holdings (NASDAQ:MEDP) Shareholders Have Earned a 48% CAGR Over the Last Five Years

在過去五年中,Medpace Holdings(納斯達克股票代碼:MEDP)股東的複合年增長率爲48%
Simply Wall St ·  05/23 00:49

Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly amazing gains over the years. Just think about the savvy investors who held Medpace Holdings, Inc. (NASDAQ:MEDP) shares for the last five years, while they gained 602%. And this is just one example of the epic gains achieved by some long term investors. It really delights us to see such great share price performance for investors.

購買最好的企業股票可以爲您和您的家人創造有意義的財富。多年來,我們已經看到了一些真正驚人的收益。想想那些持有Medpace Holdings, Inc. (NASDAQ:MEDP)股票的明智投資者,在過去的五年中,他們的收益率增長了602%。這僅僅是一位長期投資者獲得的史詩級收益的一個例子。我們真的很高興看到投資者的股價表現那麼好。

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

現在值得更詳細地了解該公司的基本面,因爲這將幫助我們判斷長期股東回報是否與基礎業務的表現相匹配。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

在他的文章《格雷厄姆和多德斯維爾超級投資者》中,禾倫·巴菲特描述了股票價格並不總是反映公司價值的合理方式。考慮市場對公司的看法如何發生變化的一個不完美但簡單的方法是將每股收益(EPS)的變化與股價的變動進行比較。股票價格並不總是反映公司價值的合理方式在股價上漲的5年中,新加坡交易所由虧損逐漸轉爲盈利。而在之後的12個月內,該公司的財務報表則呈虧損狀態,這表明它的盈利能力不可靠。其他指標可能會更好地反映公司的價值變化。

Over half a decade, Medpace Holdings managed to grow its earnings per share at 36% a year. This EPS growth is slower than the share price growth of 48% per year, over the same period. So it's fair to assume the market has a higher opinion of the business than it did five years ago. And that's hardly shocking given the track record of growth.

在五年時間裏,Medpace Holdings的每股收益年均增長36%。與此同時,同期股價增長率爲48%,股價增長速度略快。因此,可以認爲市場對該公司的看法比五年前更高。鑑於其成長記錄,這並不足爲奇。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下面的圖片中查看每股收益如何隨時間變化(單擊圖表以查看確切的價值)。

earnings-per-share-growth
NasdaqGS:MEDP Earnings Per Share Growth May 22nd 2024
NasdaqGS:MEDP每股收益增長於2024年5月22日。

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. It might be well worthwhile taking a look at our free report on Medpace Holdings' earnings, revenue and cash flow.

值得注意的是,該公司CEO的收入低於同等規模公司的中位數水平。CEO的薪酬總是值得留意,但更重要的問題是公司是否會在未來幾年內增長收益。您可以免費查看我們的報告,了解Medpace Holdings的收益、營業收入和現金流。

A Different Perspective

不同的觀點

It's nice to see that Medpace Holdings shareholders have received a total shareholder return of 93% over the last year. That's better than the annualised return of 48% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 1 warning sign for Medpace Holdings you should be aware of.

很高興看到Medpace Holdings股東在過去一年中獲得了93%的股東回報率。這比過去五年48%的年化回報率更好,表明公司最近表現更好。考慮到股價勢頭仍然強勁,值得更加密切地關注這支股票,以免錯失機會。我發現長期股價是企業表現的代理很有趣,但要真正獲得見解,我們需要考慮其他信息。例如:我們發現Medpace Holdings存在1個警告信號,您應該注意到。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,您可能在其他地方找到一家出色的企業進行投資。因此,請查看我們預計將實現盈利增長的公司的免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論